44

3

Logo

CASIS - Cardiac Simulation & Imaging Software

Société | Quetigny, France
2

abonnés

Onglets principaux

A propos de votre organisation

Cardiovascular diseases are the leading cause of death globally. CASIS – CArdiac Simulation & Imaging Software aim at improbing patients' care by easing and securing cardiovascular conditions' diagnosis and prognosis.

Founded in 2016 as a spinoff of the Dijon university hospital,  CASIS has developped the software suite QIR Suite. It is a complete AI-based solution to analyze MR and CT examination through detection of region of the heart, pathological areas and quantification of more than 100 clinical parameters.

The market for AI-based diagnostic imaging software devices represents US$3.4 billion and 150 million patients worldwide; the cardiovascular segment being the fastest growing. CASIS is aiming for € 20 million turnover in 2026 and € 74 million in 2028. With 3 applications already on the market[, QIR-MR (CMR) and QIR-4D (4D flow imaging), QIR-CT (coronary CT), and ongoing integration with MR machine manufacturers, CASIS is well positioned to efficiently accelerate its growth.

With a strong scientific expertise in cardiovascular imaging and pathologies, AI and blood flow study, CASIS is accelerating breakthroughs in the development, manufacturing, and commercialization of cardiovascular diagnosis and prognosis support software. In particular with the world first solution to automatically evaluate a myocardial infarction. CASIS aims to facilitate the diagnosis and monitoring of pathologies such as myocarditis, myocardial infarct, heart failure, aortic aneurysm, and hypertrophic cardiomyopathies. These pathologies are responsible for 1 out of 6 deaths worldwide.

With a first patent FR1750859 – US 11,152,122 on aortic aneurysm, the company is certified ISO 13485 by GMED. Its main product, QIR Suite, is a Software As a Medical Device suite CE marked (EU market), FDA cleared (USA), PMDA cleared (Japan), and TFDA cleared (Taiwan).

CASIS has a proven international team (15 spoken languages) with the expertise to accelerate the development, validation, and manufacturing of cardiovascular software worldwide, approved by the ANSM (French governmental healthcare regulation body). CASIS technical team works tightly with a scientific committee of 12 cardiologists and radiologists worldwide (France, USA, Germany, Belgium, Japan, India, Brazil, Argentina).

CASIS current capital is 123 740€, and CASIS has been able to reach its current stage by raising a total of more than 5M€, including 1.5M€ in equity.

CASIS is now seeking a € 6 million Series A fund raising.

Proceeds from the Series A will be used to accelerate the development of its business activity and consolidate the range of its software solutions:

  • € 2.2 millions to recruit sales representatives for the US market, Japan and China (for a total of 3 seniors and 4 juniors), strengthen the R&D team and recruit a CFO;
  • € 1.3 million for regulatory clearance in USA (on-going), Taiwan (on-going), Japan, and China, business consultants, and for marketing and communication;
  • € 2.5 millions for training data to improve CASIS AI algorithms, software range extension to new offers (4D flow MR and coronary CT), and IP protection.

CASIS is looking for a prestigious group of visionary investors, who share our strategic approach, with opportunities for partnerships, growth, and a unique collaboration.

We look forward to meeting you soon.

Réseau (0)

Il n'y a pas encore d'organisations dans le réseau.

Activité récente

Vous n'êtes pas connecté(e)

Un certain nombre de contenus vous sont cachés et vous ne bénéficiez pas des fonctionnalités de mises en relation.

Log in or register pour accéder à l’intégralité des contenus et fonctionnalités d’EuroQuity : l’inscription est rapide et gratuite !